Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b.

International journal of environmental research and public health - 15 Sept 2022

De Francesco Maria Antonia, Gargiulo Franco, Zaltron Serena, Spinetti Angiola, Castelli Francesco, Caruso Arnaldo

Abstract excerpt

Approved direct antiviral agent (DAA) combinations are associated with high rates of sustained virological response (SVR) and the absence of a detectable hepatitis C viral load 12-24 weeks after treatment discontinuation. However, a low percentage of individuals fail DAA therapy. Here, we report the case of a HIV/HBV/HCV co-infected patient who failed to respond to DAA pangenotypic combination therapy. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to Hepatitis B virus

Share to Hepatitis C, Chronic

Share to Treatment Failure

Share to Viral Nonstructural Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 36141921
DOI: 10.3390/ijerph191811655
PMCID: PMC9517502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b.PMID 36141921Read ↗

Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region.Semantic proximity Read ↗

Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.Semantic proximity Read ↗

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.Semantic proximity Read ↗

Naturally occurring genotype 2b/1a hepatitis C virus in the United States.Semantic proximity Read ↗

Genetic recombination of the hepatitis C virus: clinical implications.Semantic proximity Read ↗

Productive Homologous and Non-homologous Recombination of Hepatitis C Virus in Cell CultureSemantic proximity Read ↗

Recombination in hepatitis C virus: identification of four novel naturally occurring inter-subtype recombinants.Semantic proximity Read ↗

Recombination in hepatitis C virus.Semantic proximity Read ↗

Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg-positive patients.Semantic proximity Read ↗

Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.Semantic proximity Read ↗

HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.Semantic proximity Read ↗

Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.